株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

最小侵襲脊椎デバイス:医療機器パイプライン評価 (2019年)

Minimal Invasive Spinal Devices - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 915748
出版日 ページ情報 英文 68 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
最小侵襲脊椎デバイス:医療機器パイプライン評価 (2019年) Minimal Invasive Spinal Devices - Medical Devices Pipeline Assessment, 2019
出版日: 2019年10月11日 ページ情報: 英文 68 Pages
概要

当レポートでは、世界の主要各社による最小侵襲脊椎デバイスの開発動向を調査し、開発中の製品および主要開発事業者の概要、財務動向、人事、認可、提携・協力など企業および企業間の近年の展開などをまとめています。

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • 開発ステージ別
  • 用途別
  • 地域別
  • 承認基準別
  • 推定承認日別

第4章 開発中の製品:企業別

  • 開発ステージ別

第5章 企業および製品の概要

  • Bonovo Orthopedics Inc
  • Camber Spine Technologies LLC
  • Corelink LLC
  • DePuy Synthes Inc
  • EIT Emerging Implant Technologies GmbH
  • Inion Oy
  • Integra LifeSciences Holdings Corp
  • KISCO International
  • Maxigen Biotech Inc
  • Medicrea Group
  • Medyssey Co Ltd
  • MicroPort Scientific Corp
  • OxSonics Ltd
  • Safe Orthopaedics SA
  • SeaSpine, Inc.
  • Sheba Medical Center
  • Solco Biomedical Co Ltd
  • Spinal Balance Inc.
  • Stryker Corp
  • University of South Florida
  • Vivonics Inc

第6章 最近のニュース・発表

  • Aurora Spine:業績発表
  • Solcoの脊椎固定システム:FDA認証取得
  • joimax・Red One Medical:提携
  • joimax:EndoLIF Delta・DoubleWedgeケージの販売を開始
  • Medicrea:業績発表
  • MEDICREA:UNiD ASI技術の特許を取得
  • Aurora Spine:業績発表
  • Medicrea:業績発表
  • Medicrea:AI・アナリティクス関連の年次会議を主催
  • Aurora Spine:業績発表、など

第7章 付録

図表

List of Tables

  • Table 1: Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development 7
  • Table 2: Minimal Invasive Spinal Devices - Pipeline Products by Segment 8
  • Table 3: Minimal Invasive Spinal Devices - Pipeline Products by Territory 9
  • Table 4: Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path 10
  • Table 5: Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date 11
  • Table 6: Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development 12
  • Table 7: Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development 13
  • Table 8: Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 9: Pioneer QUANTUM Spinal Rodding System - Product Status 14
  • Table 10: Pioneer QUANTUM Spinal Rodding System - Product Description 14
  • Table 11: Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 12: SPIRA Lateral - Product Status 15
  • Table 13: SPIRA Lateral - Product Description 15
  • Table 14: SPIRA Posterior Lumbar - Product Status 16
  • Table 15: SPIRA Posterior Lumbar - Product Description 16
  • Table 16: SPIRA-L Open Architecture Lateral Cage - Product Status 16
  • Table 17: SPIRA-L Open Architecture Lateral Cage - Product Description 16
  • Table 18: Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 19: Stand Alone Cervical Cage System - Product Status 17
  • Table 20: Stand Alone Cervical Cage System - Product Description 17
  • Table 21: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 22: Expandable Cage - Spine - Product Status 18
  • Table 23: Expandable Cage - Spine - Product Description 18
  • Table 24: Next Gen Spine MIS System - Product Status 19
  • Table 25: Next Gen Spine MIS System - Product Description 19
  • Table 26: EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 27: Fully Printed Lateral Expanding Cage - Product Status 20
  • Table 28: Fully Printed Lateral Expanding Cage - Product Description 20
  • Table 29: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 30: Cervical Cage - Product Status 21
  • Table 31: Cervical Cage - Product Description 21
  • Table 32: Lumbar Cage - Product Status 22
  • Table 33: Lumbar Cage - Product Description 22
  • Table 34: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 35: ESS+ Rod - Product Status 23
  • Table 36: ESS+ Rod - Product Description 24
  • Table 37: KISCO International Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 38: Cambo - Product Status 25
  • Table 39: Cambo - Product Description 25
  • Table 40: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 41: MaxiCage - Product Status 26
  • Table 42: MaxiCage - Product Description 26
  • Table 43: Medicrea Group Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 44: Self-Locking Tulip Screw - Product Status 27
  • Table 45: Self-Locking Tulip Screw - Product Description 27
  • Table 46: Medyssey Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 47: Unicorn Cs - Product Status 28
  • Table 48: Unicorn Cs - Product Description 28
  • Table 49: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 50: Cannulated Screw - Product Status 29
  • Table 51: Cannulated Screw - Product Description 29
  • Table 52: OxSonics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 53: UltraSpine - Product Status 30
  • Table 54: UltraSpine - Product Description 30
  • Table 55: Safe Orthopaedics SA Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 56: Oak screw - Cemetable Version - Product Status 31
  • Table 57: Oak screw - Cemetable Version - Product Description 31
  • Table 58: Walnut - Product Status 32
  • Table 59: Walnut - Product Description 32
  • Table 60: SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 61: PROW - Degenerative Disc Disease - Product Status 33
  • Table 62: PROW - Degenerative Disc Disease - Product Description 33
  • Table 63: PROW - Herniated Disc - Product Status 34
  • Table 64: PROW - Herniated Disc - Product Description 34
  • Table 65: PROW - Spinal Tumor - Product Status 34
  • Table 66: PROW - Spinal Tumor - Product Description 34
  • Table 67: PROW - Spondylolisthesis - Product Status 35
  • Table 68: PROW - Spondylolisthesis - Product Description 35
  • Table 69: PROW Implant - Trauma - Product Status 35
  • Table 70: PROW Implant - Trauma - Product Description 36
  • Table 71: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 72: Transarticular Cannulated Fenestrated Screw - Product Status 37
  • Table 73: Transarticular Cannulated Fenestrated Screw - Product Description 37
  • Table 74: Solco Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 75: 4CIS Chiron Spinal Fixation System - Product Status 38
  • Table 76: 4CIS Chiron Spinal Fixation System - Product Description 38
  • Table 77: Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 78: Interbody Cage - Product Status 39
  • Table 79: Interbody Cage - Product Description 39
  • Table 80: Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 81: Xia Cannulated Polyaxial Screw - Product Status 40
  • Table 82: Xia Cannulated Polyaxial Screw - Product Description 40
  • Table 83: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 84: Vertebral Body Cage - Product Status 41
  • Table 85: Vertebral Body Cage - Product Description 41
  • Table 86: Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 87: MIDIS Cage - Product Status 42
  • Table 88: MIDIS Cage - Product Description 42
  • Table 89: Glossary 67

List of Figures

  • Figure 1: Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development 7
  • Figure 2: Minimal Invasive Spinal Devices - Pipeline Products by Segment 8
  • Figure 3: Minimal Invasive Spinal Devices - Pipeline Products by Territory 9
  • Figure 4: Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path 10
  • Figure 5: Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date 11
目次
Product Code: GDME0794EPD

GlobalData's Medical Devices sector report, "Minimal Invasive Spinal Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Minimal Invasive Spinal Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Minimal Invasive Spinal Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Minimal Invasive Spinal Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Minimal Invasive Spinal Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Minimal Invasive Spinal Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Minimal Invasive Spinal Devices Overview

3 Products under Development

  • 3.1 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • 3.2 Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • 3.3 Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • 3.4 Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • 3.5 Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date

4 Minimal Invasive Spinal Devices - Pipeline Products under Development by Companies

  • 4.1 Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimal Invasive Spinal Devices Companies and Product Overview

  • 5.1 Bonovo Orthopedics Inc Company Overview
  • 5.2 Camber Spine Technologies LLC Company Overview
  • 5.3 Corelink LLC Company Overview
  • 5.4 DePuy Synthes Inc Company Overview
  • 5.5 EIT Emerging Implant Technologies GmbH Company Overview
  • 5.6 Inion Oy Company Overview
  • 5.7 Integra LifeSciences Holdings Corp Company Overview
  • 5.8 KISCO International Company Overview
  • 5.9 Maxigen Biotech Inc Company Overview
  • 5.10 Medicrea Group Company Overview
  • 5.11 Medyssey Co Ltd Company Overview
  • 5.12 MicroPort Scientific Corp Company Overview
  • 5.13 OxSonics Ltd Company Overview
  • 5.14 Safe Orthopaedics SA Company Overview
  • 5.15 SeaSpine, Inc. Company Overview
  • 5.16 Sheba Medical Center Company Overview
  • 5.17 Solco Biomedical Co Ltd Company Overview
  • 5.18 Spinal Balance Inc. Company Overview
  • 5.19 Stryker Corp Company Overview
  • 5.20 University of South Florida Company Overview
  • 5.21 Vivonics Inc Company Overview

6 Minimal Invasive Spinal Devices- Recent Developments

  • 6.1 Aug 22, 2019: Aurora Spine reports record Q2 revenue; files condensed interim consolidated financial statements for the three and six months ended June 30, 2019
  • 6.2 Aug 13, 2019: FDA Oks Solco's spinal fixation system
  • 6.3 Aug 06, 2019: joimax and Red One Medical partner to support expert endoscopic minimally invasive spine surgery for veterans and active military
  • 6.4 Jul 15, 2019: joimax starts the official sale of its EndoLIF Delta and DoubleWedge cages. All three members of EndoLIF family CE approved.
  • 6.5 Jul 09, 2019: Medicrea reports first half 2019 sales
  • 6.6 Jun 17, 2019: MEDICREA secures several new patents to protect its proprietary platform technology UNiD ASI
  • 6.7 May 30, 2019: Aurora Spine reports record Q1 revenue
  • 6.8 May 17, 2019: Medicrea announces first quarter 2019 financial results
  • 6.9 May 14, 2019: Medicrea hosts second annual meeting focused on Artificial Intelligence and Analytics in New York, USA
  • 6.10 Apr 26, 2019: Aurora Spine announces 2018 year end results
  • 6.11 Apr 18, 2019: MEDICREA enhances its proprietary UNiD ASI Service Platform with the addition of an FDA-Cleared device planning and selection service
  • 6.12 Apr 10, 2019: Medicrea reports first quarter 2019 sales
  • 6.13 Mar 28, 2019: SpineGuard receives regulatory Clearance in Taiwan and starts PediGuard commercialization
  • 6.14 Mar 22, 2019: Medicrea announces 2018 annual results
  • 6.15 Mar 13, 2019: Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
  • 6.16 Mar 12, 2019: joimax hosts international training summit to showcase innovative technologies
  • 6.17 Feb 12, 2019: Dr. Raymond Gardocki of the Campbell Clinic in Memphis, TN, performs his 100th endoscopic spine surgery utilizing joimax technologies
  • 6.18 Feb 08, 2019: joimax announces new distribution partners in Brazil and Japan
  • 6.19 Jan 23, 2019: Aurora Spine announces new patent for its Minimally Invasive Spinal Implants allowed by the United States Patent Office
  • 6.20 Jan 16, 2019: Medicrea reports 2018 fourth quarter and annual sales
  • 6.21 Nov 22, 2018: Aurora Spine Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2018
  • 6.22 Nov 19, 2018: MEDICREA achieves 3,000 surgery milestone with UNiD ASI and patient specific implants
  • 6.23 Nov 15, 2018: Medicrea reports third-quarter results
  • 6.24 Nov 05, 2018: Medicrea to attend the 9th Annual Craig-Hallum Alpha Select Conference
  • 6.25 Nov 05, 2018: Rapid company growth prompts joimax to move its US headquarters to a new, larger state-of-the-art facility
  • 6.26 Oct 22, 2018: Medline awarded lab distribution agreement with Premier
  • 6.27 Oct 10, 2018: Leading into SRS 2018, Medicrea highlights a new study showing that patients implanted with UNiD patient-specific rods are 2.6 times more likely to be optimally corrected

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top